Professor William Herrington is an Honorary Consultant Nephrologist at Oxford Kidney Unit and the Professor of Trials and Epidemiology of Kidney Disease at the Nuffield Department of Population Health, University of Oxford.
Prof Herrington earned his MD from the University of Cambridge in 2013, focusing on the impact of lowering LDL cholesterol on stroke in chronic kidney disease.
He has previously chaired the UK Renal Trials Network and is Chief Investigator of the EASi-KIDNEY trial and the EMPA-KIDNEY trial. Since co-leading the Renal Studies Group in 2010, he has trained on landmark renal trials as a Clinical Research Fellow. He has also contributed to clinical guideline working groups for organisations like the European Society of Cardiology and the UK Kidney Association.
His research interests include renal epidemiology, trial methodology, and cardiovascular disease in chronic kidney disease. His studies focus on the effects of LDL cholesterol, blood pressure, and FGF23 on kidney health, as well as the public health implications of obesity and diabetes.
